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Abstract: The promising antimicrobial activity of essential oils (EOs) has led researchers to use them
in combination with antimicrobial drugs in order to reduce drug toxicity, side effects, and resistance
to single agents. Mentha x piperita, known worldwide as “Mentha of Pancalieri”, is produced locally
at Pancalieri (Turin, Italy). The EO from this Mentha species is considered as one of the best mint EOs
in the world. In our research, we assessed the antifungal activity of “Mentha of Pancalieri” EO, either
alone or in combination with azole drugs (fluconazole, itraconazole, ketoconazole) against a wide
panel of yeast and dermatophyte clinical isolates. The EO was analyzed by GC-MS, and its antifungal
properties were evaluated by minimum inhibitory concentration (MIC) and minimum fungicidal
concentration (MFC) parameters, in accordance with the CLSI guidelines, with some modifications.
The interaction of EO with azoles was evaluated through the chequerboard and isobologram methods.
The results suggest that this EO exerts a fungicidal activity against yeasts and a fungistatic activity
against dermatophytes. Interaction studies with azoles indicated mainly synergistic profiles between
itraconazole and EO vs. Candida spp., Cryptococcus neoformans, and Trichophyton mentagrophytes.
Thus, the “Mentha of Pancalieri” EO may act as a potential antifungal agent and could serve as a
natural adjuvant for fungal infection treatment.
Keywords: essential oils; Mentha x piperita; “Mentha of Pancalieri”; azoles; antifungal activity; yeasts
and dermatophytes; synergism
1. Introduction
With the wide use of synthetic and semi-synthetic antimicrobial drugs, their advantages and
disadvantages have been highlighted over the years, including the spread of drug-resistant pathogens,
and research has focused on the use of natural products as useful antimicrobial tools [1]. Currently,
there is evidence that essential oils (EOs) may exert remarkable biological activities against viruses,
bacteria, fungi, and parasites [1,2]. Furthermore, the promising antimicrobial activity of EOs has led
researchers to use them in association with antimicrobial drugs in order to reduce toxicity, side effects,
and microbial resistance. Several EOs are generally recognized as safe, do not accumulate in the liver
or kidneys, can stimulate the immune system [3–5], and cause no resistance, since microbes are unable
to adapt to their heterogeneous structures [6]. Mentha x piperita L. (peppermint) EO is one of the
most widely produced and consumed EOs. Data show that peppermint EO and its main components
(menthol and menthone) display antimicrobial effects, but their mechanism of action has still not been
elucidated [7–10]. Near Turin (Piedmont, Italy), in Pancalieri, Mentha x piperita (Huds) var. Officinalis
(Sole), form Rubescens (Camus) (Lamiaceae) is produced locally. This mint is known worldwide as
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“Mentha of Pancalieri” or “Mint Italo-Mitcham”. In herbal medicine, it is used in the form of the green
plant that is dried for conservation or the EO obtained from steam current distillation of the whole
plant (not shredded) [11]. The cultivation and distillation processes of this plant represents a secular
tradition. Thanks to its high quality and uniqueness, the EO from “Mentha of Pancalieri” is actually
considered by experts to be one of the best peppermint EOs in the world. Due to the continuous
increase in fungal infections and the development of azole-resistant fungal strains, in our research,
we assessed the antifungal activity of “Mentha of Pancalieri” EO against a wide panel of yeast and
dermatophyte clinical isolates. Furthermore, the possible synergistic interaction of the EO with azoles,
commonly used drugs in fungal infection treatment, was evaluated. Lastly, the anti-dermatophytic
activity of the main components of the EO (menthol and menthone) and their interaction with azoles
were assessed.
2. Results
The phytochemical composition of the “Mentha of Pancalieri” EO was confirmed to be rich
in oxygenated monoterpenes (menthol 41.7%; menthone 21.8%), in accordance with data from the
European Pharmacopoeia 8th Ed. (Table 1).
Table 1. Phytochemical composition of “Mentha of Pancalieri” essential oil (EO) in comparison with
the European Pharmacopeia indications for Mentha x piperita (Lamiaceae) essential oil.
Main Components Mentha of Pancalieri EO (Peak Area %) 1 Eur. Ph. 8th ed. (Peak Area %)
Limonene 1.8 1–3.5
1,8-Cineole 5.3 3.5–8
Menthone 21.8 2 14–32
Isomenthone 1.5 1.5–10
Menthil-acetate 4.8 2.8–10
Isopulegole 0.16 max 0.2
Menthol 41.7 2 30–55
1 Relative percentages of individual components expressed as the % peak area relative to the total composition of
the EO obtained by the GC-MS analysis 2 Main components.
The “Mentha of Pancalieri” EO was found to exert good inhibitory activity against all tested
fungal strains (Table 2), in comparison with azole drugs (Tables 4–6).
Notably, this EO exerted the most remarkable antifungal activity against Cryptococcus neoformans,
displaying the lowest minimum inhibitory concentration (MIC) and minimum fungicidal concentration
(MFC) values (Table 2, range 0.06–0.125%, v/v). Higher antimicrobial activity was also detected against
dermatophytes (MIC = 0.125%, v/v for Microsporum species) and other non-Candida yeasts, such as
Saccharomyces cerevisiae, and Pichia carsonii (MIC range 0.125–0.5 and 0.125–0.25%, v/v, respectively). It
should be noted that the EO also showed non-negligible activity against Candida krusei and C. glabrata,
yeasts that are often resistant to conventional drugs. Based on the MFC results, the “Mentha of
Pancalieri” EO was found to display fungicidal activity against yeast cells (MIC = MFC) and fungistatic
activity against dermatophytes. In fact, MFC values for dermatophytes were found to be one or two
concentrations higher than MIC values.
The two main components of the “Mentha of Pancalieri” EO, menthol and menthone, were also
evaluated against dermatophytes (Table 3). The results indicated that menthol possessed much
lower MIC values (range 0.06–0.25%, v/v) against dermatophytes, in particular, against Trichophyton
mentagrophytes (MIC = 0.06%, v/v) than menthone (MIC = 0.5–1%, v/v) and EO (MIC = 0.125–0.5%, v/v).
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Table 2. MIC 1 and MFC 2 ranges of “Mentha of Pancalieri” essential oil towards yeasts and
dermatophytes from clinical and ATCC strains.
Species Isolates (no.) MIC Range (%, v/v) MFC Range (%, v/v)
Candida spp.
Candida albicans ATCC 90028 0.5 1
Candida albicans 6 0.5–1 0.5–1
Candida glabrata ATCC 90030 0.5 0.5
Candida glabrata 2 0.5 0.5–1
Candida krusei 1 0.25 >1
Candida parapsilosis 1 0.5 0.5
Candida tropicalis 1 1 1
Candida valida 2 0.25–0.5 0.25–0.5
Candida lusitaniae 1 0.5 0.5
Candida norvegensis 2 0.25–0.5 0.25–0.5
non-Candida spp.
Cryptococcus neoformans 7 0.06–0.125 0.06–0.125
Saccharomyces cerevisiae 4 0.125–0.5 0.25–1
Pichia carsonii 2 0.125–0.25 0.125–1
Sporobolomyces
salmonicolor 1 0.5 1
Kloekera japonica 1 0.5 0.5
Dermatophytes
Trichophyton
mentagrophytes 2 0.5 >1
Microsporum canis 2 0.125 >1
Microsporum gypseum 1 0.125 >1
1 MIC = minimum inhibitory concentration; 2 MFC = minimum fungicidal concentration.
Table 3. MIC 1 and MFC 2 ranges of menthol and menthone, the main components of “Mentha of
Pancalieri” essential oil towards dermatophytes clinical strains.
Dermatophytes (no.) Mentha of Pancalieri EO (%, v/v) Menthol (%, v/v) Menthone (%, v/v)
Trichophyton
mentagrophytes (2) MIC 0.5 0.06 0.5
MFC >1 0.25 1
Microsporum canis (2) MIC 0.125 0.25 0.5–1
MFC >1 1 >1
Microsporum gypseum (1) MIC 0.125 0.25 1
MFC >1 1 1
1 MIC = minimum inhibitory concentration; 2 MFC = minimum fungicidal concentration.
No significant differences in inhibitory concentrations were found between azole-susceptible (S)
and azole-resistant (R) strains (Tables 4 and 5), with similar MIC values observed in the presence of the
“Mentha of Pancalieri” EO.
By chequerboard testing, binary combinations of fluconazole (FLC) with the “Mentha of Pancalieri”
EO were found to be additive (0.5 < FICI ≤ 1; FICI = fractional inhibitory concentration index) against
either both azole-S C. albicans and azole-S C. glabrata strains (Table 4). Notably, when synergistic
or additive effects were not observed, no antagonism was reported, since binary mixtures of
FLC/peppermint EO yielded indifferent effects on the azole-R C. krusei strain (FICI = 2). Notably,
the combinatorial effects between itraconazole (ITZ) and the “Mentha of Pancalieri” EO were found to
be synergistic (FICI ≤ 0.5) against all Candida spp. strains (Table 4). Moreover, the isobologram profiles
confirmed synergistic associations between ITZ and the “Mentha of Pancalieri” EO (Figure 1a–c).
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Table 4. MIC 1 and FICI 2 of the “Mentha of Pancalieri” EO plus fluconazole or itraconazole against
azole-S/R Candida spp. strains.
Antifungals C. albicansAzole-S Strain 3
C. glabrata Azole-S */R
** Strain3
C. krusei Azole-R
Strain 3
Mentha of Pancalieri EO MIC (%, v/v) alone 0.5 0.5 0.25
Fluconazole MIC (µg/mL) alone 0.12 4 * 64
FIC of EO 0.5 0.5 1
FIC of FLC 0.12 0.12 1
FICI 0.62 0.62 2
Interpretation ADD 4 ADD IND
Mentha of Pancalieri EO MIC (%, v/v) alone 0.5 0.5 0.25
Itraconazole MIC (µg/mL) alone 0.5 2 ** 2
FIC of EO 0.12 0.25 0.25
FIC of ITZ 0.12 0.25 0.25
FICI 0.24 0.5 0.5
Interpretation SYN 4 SYN SYN
1 MIC = minimum inhibitory concentration; 2 FICI = fractional inhibitory concentration index; 3 breakpoints
determining susceptibility/resistance to fluconazole (FLC) and itraconazole (ITZ) according to the CLSI document:
FLC S ≤ 0.125 µg/mL and R ≥ 4 µg/mL (C. albicans), FLC R ≥ 64 µg/mL C. glabrata); C. krusei is basically resistant to
FLC; ITZ S ≤ 0.125 µg/mL and R ≥ 1 µg/mL (C. krusei, C. glabrata) [12,13] 4 ADD: additive; IND: indifferent; SYN:
synergy. *= azole susceptible (S) strain; ** = azole resistant (R) strain.
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Table 5. MIC 1 and FICI 2 of the “Mentha of Pancalieri” EO plus itraconazole against azole-S/R
Cryptococcus neoformans.
Antifungals C. neoformans Azole-S Strain C. neoformans Azole-R Strain
Mentha of Pancalieri EO MIC (%, v/v) alone 0.06 0.06
Itraconazole MIC (µg/mL) alone 0.5 2
FIC of EO 0.12 0.5
FIC of ITZ 0.25 0.12
FICI 0.37 0.62
Interpretation SYN 3 ADD
1 MIC = minimum inhibitory concentration; 2 FICI = fractional inhibitory concentration index 3 ADD: additive;
SYN: synergy.
In accordance with the FIC index values described for theC. neoformans azole-S isolate, the “Mentha
of Pancalieri” EO was found to exert a synergistic profile (Table 5, FICI ≤ 0.5), with a decrease in the
MIC, as expressed by the isobologram in Figure 2. On the contrary, concerning the C. neoformans
azole-R strain, the binary combination of ITZ/peppermint EO yielded additive effects (FICI = 0.62).
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Figure 2. Isobologram of synergistic interactions: plot of “Mentha of Pancalieri” EO and ITZ against
the Cryptococcus neoformans azole-S strain. ITZ FIC data are drafted on the x-axis, while EO FIC values
are drafted on the y-axis.
By chequerboard testing, binary combinations of ITZ/KTZ with the “Mentha of Pancalieri” EO
were found to be synergistic (Table 6, FICI ≤ 0.5) against T. mentagrophytes, as represented by the
corresponding isobologram in Figure 3a,b. Conversely, indifferent interactions of ITZ/KTZ and “Mentha
of Pancalieri” EO binary mixtures were recorded against either Microsporum canis or M. gypseum strains
(Table 6, 1 < FICI < 4). Furthermore, results about menthol and menthone in combination with ITZ or
KTZ indicated only an additive activity (FICI = 0.75–1) of these components against T. mentagrophytes
(Table 7).
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Table 6. MIC 1 and FICI 2 of the “Mentha of Pancalieri” EO plus itraconazole or ketoconazole
against dermatophytes.
Antifungals Trichophytonmentagrophytes Microsporum canis
Microsporum
gypseum
Mentha of Pancalieri EO MIC (%, v/v) alone 0.5 0.125 0.125
Itraconazole MIC (µg/mL) alone 0.5 1 1
FIC of EO 0.25 1 1
FIC of ITZ 0.12 0.03 0.125
FICI 0.37 1.03 1.125
Interpretation SYN 3 IND 3 IND
Mentha of Pancalieri EO MIC (%, v/v) alone 0.5 0.125 0.125
Ketoconazole MIC (µg/mL) alone 2 4 2
FIC of EO 0.25 1 1
FIC of KTZ 0.12 0.015 0.015
FICI 0.37 1.015 1.015
Interpretation SYN IND IND
1 MIC = minimum inhibitory concentration; 2 FICI = fractional inhibitory concentration index; 3 IND: indifferent;
SYN: synergy.
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Table 7. MIC 1 and FICI 2 of menthol and menthone plus itraconazole or ketoconazole against
Trichophyton mentagrophytes.
Compounds Trichophyton mentagrophytes
Menthol MIC (%, v/v) alone 0.06
Itraconazole MIC (µg/mL) alone 0.5
FIC of menthol 0.5
FIC of ITZ 0.5
FICI 1
Interpretation ADD 3
0.125
Menthol MIC (%, v/v) alone 0.06
Ketoconazole I (µg/mL 2
FIC of menthol 0.5
FI of KTZ 0.5
FICI 1
Interpretation ADD
Molecules 2019, 24, 3148 7 of 12
Table 7. Cont.
Compounds Trichophyton mentagrophytes
Menthone MIC (%, v/v) alone 0.5
Itraconazole MIC (µg/mL) alone 0.5
FIC of menthone 0.25
FIC of ITZ 0.5
FICI 0.75
Interpretation ADD
0.125
Menthone MIC (%, v/v) alone 0.5
Ketoconazole MIC (µg/mL) alone 2
FIC of menthone 0.5
FIC of KTZ 0.5
FICI 1
Interpretation ADD
1 MIC = minimum inhibitory concentration; 2 FICI = fractional inhibitory concentration index;3 ADD: additive.
3. Discussion
To our knowledge, this is the first time that antifungal activity of the “Mentha of Pancalieri”
EO, a local variety of Mentha x piperita (“Mint Italo-Mitcham”), alone and/or in combination with
antifungal drugs has been studied. In fact, literature data mainly concernMentha x piperita (peppermint).
The leaves of peppermint (fresh and dried) and its EO are very well known herbal medicinal products
that have been widely used for a long time. They represent a popular remedy inside and outside
European countries due to their antispasmodic, choleretic, and carminative properties [14,15]. Some
studies have demonstrated that Mentha x piperita EO possesses antimicrobial properties and antioxidant
activity [15]. In addition, Mentha x piperita EO is capable of inhibiting the production of Candida and
other microbial biofilms [16–18], reducing the amount of exoproteins associated with Staphylococcus
aureus virulence at subMIC concentrations in a dose-dependent manner [19]. In this study, “Mentha of
Pancalieri” EO exhibited higher antimicrobial activity towards C. neoformans, S. cerevisiae, and P. carsonii
and displayed good antimicrobial activity towards C. krusei and C. glabrata—species that are often
resistant to conventional drugs. This antifungal activity towards yeast strains is probably consistent
with that of Mentha x piperita L. EO that is able to carry out anticandidal activity with consequent cell
“death” by decreasing the amount of ergosterol and producing intracellular acidification following
PM-ATPase inhibition [4]. Recent studies have shown that Mentha x piperita L. EO inactivates S.
cerevisiae, a species that deteriorates fruit juices through the disorder of several physiological functions,
i.e., enzymatic activity, efflux pump activity, and early apoptosis [20].
The activity of the “Mentha of Pancalieri” EO was also assessed against some etiological agents of
dermatophytosis (T. mentagrophytes, M. canis and M. gypesum), usually treated with azoles. “Mentha of
Pancalieri” EO showed higher activity against these dermatophytes than azole drugs and displayed
fungistatic activity (Tables 2 and 6), in agreement with a study by Ibrahim et al. with Mentha x piperita
L. EO [8].
The antimicrobial activity of “Mentha of Pancalieri” EO can be mainly related to menthol and/or
menthone, the main compounds contained in the EO [10]. However, this activity may be due to a
possible synergy between all of the EO components [15,16]. In fact, while our MIC results for menthol
(Table 3) indicated a better activity of this component against dermatophytes in comparison with EO
in toto, the MIC values of menthone for Microsporum spp. (Table 3) were found to be twice as high as
those observed with the EO in toto.
Since drug combinations represent a promising strategy for the development of new antifungal
strategies, in order to overcome drug resistance, limit the side effects and toxicity of drugs, and increase
therapeutic efficacy [16,21], in this research, we assessed the combined effect of “Mentha of Pancalieri”
EO and three antifungal azoles: FLC, ITZ, and KTZ. Our data show a synergistic interaction between
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ITZ and “Mentha of Pancalieri” EO against Candida spp., C. neoformans, and T. mentagrophytes, with a
noteworthy reduction in the concentration of azoles at the MIC. However, our FICI results for menthol
and menthone in combination with ITZ or KTZ indicated only an additive activity (FICI = 0.75–1;
Table 7) of these components against dermatophytes in comparison with EO in toto, suggesting once
again that the activity of an EO is due to the phytocomplex that expresses its effectiveness better.
Taken together, these results suggest that “Mentha of Pancalieri” EO exhibits high antifungal
activity and may have potential effectiveness as an adjuvant in association with ITZ or KTZ. Further
studies on the mechanism of action of synergistic combinations as well as in vivo preclinical models
are needed to predict the potential use of these data in clinical settings.
4. Materials and Methods
4.1. Essential Oil
Commercial “Mentha of Pancalieri” EO, obtained from the fresh leaves of Menthax piperita (Huds)
var. Officinalis (Sole), form Rubescens (Camus) (Lamiaceae) by steam distillation, was purchased
from Erbe Aromatiche Essenzialmenta, Pancalieri (Turin, Italy; http://www.essenzialmenta.it/).
The composition of “Mentha of Pancalieri” EO was analyzed by GC-MS at the Drug Science and
Technology Department (University of Turin, Italy) with a Supelcowax capillary column (Supelco,
Bellefonte, PA, USA) as previously described [22]. Menthol (2-isopropyl-5-methylcyclohexanol
(≥98% purity) and menthone [2-isopropyl-5-methylcyclohexanone, ≥97% purity] were purchased
from Sigma-Aldrich (Milan, Italy) and were used without further purification. For susceptibility
testing, EO and its components were dissolved in ethanol (1:2.5), and diluted (1:20) up to 2% (v/v) in
RPMI-1640 medium with L-glutamine and without sodium bicarbonate (Sigma-Aldrich), as previously
described [23]. Then, 0.165 M of morpholinepropanesulfonic acid (MOPS) (Sigma-Aldrich) and 0.2%
glucose were added to the EO/components solutions. The final pH was 7.0. The EO and components
were protected from light and humidity and maintained at 4 ◦C until just before use [23].
4.2. Antifungal Agents
Fluconazole (FLC; F8929), itraconazole (ITZ; I6657), and ketoconazole (KTZ; K1003) powders
(≥98% purity by HPLC) were obtained from Sigma-Aldrich. FLC solution was prepared in sterile
distilled water, whereas ITZ and KTZ solutions were prepared in 100% DMSO (Sigma-Aldrich).
The solutions were stored at −20 ◦C until just before use [21].
4.3. Fungal Strains
Sixteen Candida spp. (C. albicans, C. glabrata, C. krusei, C. parapsilosis, C. tropicalis, C. valida,
C. lusitaniae, C. norvegensis), 15 non-Candida spp. clinical strains (C. neoformans, S. cerevisiae,
Kloekera japonica, P. carsonii, Sporobolomyces salmonicolor), and five dermatophyte clinical isolates
(T. mentagrophytes, M. canis, M. gypseum) were tested (Table 2). C. albicans ATCC 90028 and
C. glabrata ATCC 90030 were also included.
Yeast identification was conducted by the API ID32C system (BioMérieux, Rome, Italy).
Then, strains were maintained at –80 ◦C in Microbanks™ (Pro-Lab Diagnostics, Neston, UK) and
cultured twice on Sabouraud dextrose agar (SDA, Oxoid, Milan, Italy) at 35 ◦C for 72 h before the
assays. Dermatophyte identification was carried out by macroscopic and microscopic observations of
the colonies and reproductive structures after 15 days of incubation on Mycobiotic agar at 25 ◦C (Merck,
KGAA, Darmstadt, Germany) [23,24]. Molds were stored in SDA at 4 ◦C until use. For susceptibility
testing, non-germinated conidial suspensions were prepared as previously described [23].
4.4. In Vitro Antifungal Susceptibility Assays
Fungal strains were assayed for susceptibility to “Mentha of Pancalieri” EO and its components
and to azoles (FLC, ITZ, KTZ) by a broth microdilution method, in accordance with the CLSI guidelines
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(CLSI M27-A3 and M27-S4 [25,26] for yeasts and CLSI M38-A2 [27] for dermatophytes), with some
modifications for the EO and components [21,23]. Tween 80 (Sigma-Aldrich) (final concentration 0.001%,
v/v) was employed to enhance EO solubility without precluding fungal proliferation. The final EO
concentration ranged from 1% to 0.0019% (v/v), and the maximum ethanol concentration was 1.5% (v/v).
Growth controls consisted of RPMI-1640 medium, and RPMI-1640 contained 1.5% (v/v) ethanol with
no inhibitory effect on fungal growth at this concentration [23]. Blastoconidia yeast suspensions and
dermatophyte conidial suspensions were prepared to yield the final inocula of ~1.5 × 103 CFU/mL and
~1.5× 104 CFU/mL, respectively [21,23]. Microdilution plates were set up, as previously described [21,23],
and yeast strains were incubated at 35 ◦C for 24 h, whereas dermatophytes were incubated at 30 ◦C for 7
days. All fungal species were tested in triplicate. The MIC values of FLC, ITZ, and KTZ were determined
visually as the lowest concentration of drug that produced complete inhibition (dermatophytes) or a
significant reduction (≥50% inhibition, yeasts) in growth in comparison with the control. MIC values of
EO were considered to represent the lowest concentration with no visible growth. The MFC values were
determined by inoculating 10 µL from non-turbid wells on SDA agar plates incubated for 3 (yeasts)
and 4 (dermatophytes) days at 30 ◦C or at 35 ◦C (Cryptococcus sp). The MFC was defined as the lowest
concentration resulting in no growth or fewer than three colonies to obtain approximately 99.9% killing
activity on subculture from the MIC [21,23].
4.5. Checkerboard Assays and Evaluation of the Fractional Inhibitory Concentration Index
A two-dimensional checkerboard with serial two-fold dilutions below the MIC to 2× the MIC
of each compound was performed in a 96-well microtiter plate, as previously described [21,28].
Microorganism suspensions were joined to each well containing mixtures of azole drug/EO or its
components. FICI values were calculated according to the following formula [28]: FICI = FICa + FICb
= MICa in combination/MICa tested alone + MICb in combination/MICb tested alone, where MICa and
MICb are the MICs of azole and the EO or the component used alone. Synergy and antagonism were
defined by FICI values of ≤0.5 and > 4, respectively. A FICI value between 0.5 and 1.0 was interpreted
as additive, whereas a value between 1.0 and 4.0 was interpreted as indifferent [28].
4.6. Isobolograms
Data from the checkerboard assays are expressed graphically by isobolograms, as previously
described [21,28]. The FIC values of the azole drug are reported on the y-axis, whereas FIC values of
EO are reported on the x-axis. The straight line that joins the intercept points is the line of additivity
(FICI = 1). Below this line, we can find the additive area (0.5 < FICI ≤ 1) and synergistic (FICI ≤ 0.5)
effects, respectively. FICI values above the straight line correspond to indifferent (1 < FICI < 4) or
antagonistic (FICI > 4) interactions [28].
4.7. Data Analysis
Results were obtained from three independent experiments performed in triplicate and expressed
as modal results.
5. Conclusions
“Mentha of Pancalieri” showed good antifungal activity against several important fungal
pathogens, including C. krusei and C. glabrata, which are often resistant to conventional
antimicrobial agents.
Interaction studies with azoles indicated mainly synergistic profiles between ITZ and this EO vs.
Candida spp., C. neoformans, and T. mentagrophytes. The EO of “Mentha of Pancalieri” contains mainly
menthol (41.7%) and menthone (21.8%), which contribute to its good antifungal activity, according to
guidelines of other countries and the European Pharmacopeia. However, our results are difficult to
compare with literature data because of the different methodologies used in experimental procedures
and the different Mentha x piperita L. EO compositions. For example, the EO acquired from the dried
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leaves of Mentha x piperita in Brazil contains 51% linalool as the main compound [29], probably due to
the different cultivation conditions. It is very important that mint cultivation and EO production are
strictly controlled, because it is recognized that the chemical composition of mint EOs, as well as all
EOs, can be influenced by many factors including humidity, nutrients, and temperature. From this
point of view, “Mentha of Pancalieri” has a guaranteed controlled composition and, consequently, high
quality, which makes it an effective product for exploitation.
In conclusion, “Mentha of Pancalieri” EO may act as a potential antifungal agent and may serve
as a natural adjuvant for fungal infection treatment. Hence, this EO may represent a more effective
and less toxic alternative to antifungal drugs. Further research is necessary to confirm these data.
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